Pediatrix Medical Group Inc (NYSE: MD) is 27.96% higher on its value in year-to-date trading and has touched a low of $6.62 and a high of $13.01 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MD stock was last observed hovering at around $12.08 in the last trading session, with the day’s loss setting it -0.18%.
Currently trading at $11.90, the stock is 9.08% and 16.32% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.62 million and changing -1.49% at the moment leaves the stock 31.57% off its SMA200. MD registered -6.30% loss for a year compared to 6-month gain of 28.93%. The firm has a 50-day simple moving average (SMA 50) of $10.3144 and a 200-day simple moving average (SMA200) of $9.0589.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 12.90% loss in the last 1 month and extending the period to 3 months gives it a 74.74%, and is 4.75% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.85% over the week and 3.93% over the month.
Pediatrix Medical Group Inc (MD) has around 8070 employees, a market worth around $1.02B and $2.00B in sales. Fwd P/E is 8.17. Profit margin for the company is -12.58%. Distance from 52-week low is 79.76% and -8.53% from its 52-week high. The company has generated returns on investments over the last 12 months (-18.41%).
Pediatrix Medical Group Inc quarterly earnings per share for the current quarter are estimated at 0.37 with sales reaching $498.87M over the same period.The EPS is expected to grow by 1.21% this year, but quarterly earnings will post -0.60% year-over-year. Quarterly sales are estimated to shrink -1.50% in year-over-year returns.
317.0 institutions hold shares in Pediatrix Medical Group Inc (MD), with institutional investors hold 109.71% of the company’s shares. The shares outstanding are 85.87M, and float is at 84.59M with Short Float at 5.67%. Institutions hold 107.88% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 13.69 million shares valued at $103.38 million. The investor’s holdings represent 16.432 of the MD Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 10.55 million shares valued at $79.69 million to account for 12.6655 of the shares outstanding. The other top investors are RUBRIC CAPITAL MANAGEMENT LP which holds 8.15 million shares representing 9.7802 and valued at over $61.53 million, while ALLIANCEBERNSTEIN L.P. holds 9.2466 of the shares totaling 7.71 million with a market value of $58.18 million.
Pediatrix Medical Group Inc (MD) Insider Activity
The most recent transaction is an insider sale by Swift James D, the company’s Chief Executive Officer. SEC filings show that Swift James D sold 11,100 shares of the company’s common stock on Aug 30 ’24 at a price of $10.79 per share for a total of $0.12 million. Following the sale, the insider now owns 0.17 million shares.
Still, SEC filings show that on Aug 27 ’24, Linynsky Laura A (Director) disposed off 7,000 shares at an average price of $11.16 for $78120.0. The insider now directly holds 30,805 shares of Pediatrix Medical Group Inc (MD).
